Modulation of the activity of N-methyl-D-aspartate receptors as a novel treatment option for depression: Current clinical evidence and therapeutic potential of rapastinel (GLYX-13)
Andrei Nicolae Vasilescu, Nina Schweinfurth, Stefan Borgwardt, Peter Gass, Undine E. Lang*, Dragos Inta, Sarah Eckart
*Korrespondierende/r Autor/-in für diese Arbeit
22
Link öffnet neuen Tab
Zitate (Scopus)